Market News / Story

AngioDynamics, Inc. (ANGO) Q1 Sales $80.9M, +6.9% YoY; Names New CEO

·

AngioDynamics reported Q1 FY27 net sales of $80.9M, up 6.9% YoY, gross margin 59.4%, and an adjusted net loss of $1.8M. The company reiterated FY27 guidance and said Eric Honroth will become CEO effective Nov. 2, 2026. Material Details #DetailAI Analyst View1Q1 sales $80.9M, +6.9% YoYTop-line growth, led by Med Tech, supports the bull case.2Med Tech sales $39.9M, +13.2% YoYHigher-margin segment mix drives profitability leverage.3Gross margin 59.4% (+410 bps YoY)Margin…

VIEW SOURCE

Back to news